Stay updated on Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.

Latest updates to the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page adds new help/navigation items (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision tag to v3.6.0, while the previous label 'Intervention / Treatment' was removed and replaced with 'Intervention/Treatment'.SummaryDifference0.5%

- Check20 days agoChange DetectedThe revision tag in the page footer was updated from v3.5.4 to v3.5.5, indicating a minor software update to the page.SummaryDifference0.1%

- Check42 days agoChange DetectedA clinical study report synopsis, sponsor-related items (AbbVie), and a new 'Helpful Links Provided by AbbVie' section were added, and the page revision was updated to v3.5.4.SummaryDifference0.2%

- Check63 days agoChange DetectedThe ClinicalTrials.gov page’s footer version indicator has been updated from Revision v3.5.2 to Revision v3.5.3.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No changes to the page content or clinical information are indicated.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.